Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
06/2003
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119811 Ion channel antagonists that are NMDA antagonists; treatment of migraine, depression, anxiety, schizophrenia, Parkinson's disease, or stroke.
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003CA2473938A1 Human adam-10 inhibitors
06/26/2003CA2471500A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003CA2468978A1 Therapeutic heterocycles
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1321461A1 N-(Cyclopropylmethyl)-azacycloalkanes, compositions containing them and methods for their preparation
06/25/2003EP1320526A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
06/25/2003EP1320525A1 Antibacterial mutilins
06/25/2003EP1320524A2 Crystal modification of fexofenadine
06/25/2003EP1320366A1 Substituted piperidines as melanocortin receptor agonists
06/25/2003EP0946546B1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
06/25/2003EP0777652B1 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426407A N-(heterocyclic)-benzene or pyridine sulphozmides as antithrombotic agents and anticoagulants
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/24/2003US6583299 α-amino-β-sulfonyl hydroxamic acid compounds
06/24/2003US6583286 Method for hydrogenating unsaturated heterocyclic compounds
06/24/2003US6583179 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
06/24/2003US6583177 Leukotriene B4 antagonist compounds and method for treatment
06/24/2003US6583159 Substitute 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their preparation and therapeutic use
06/24/2003US6583158 Method for enhancing mutant enzyme activities in lysosomal storage disorders
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/21/2003CA2414905A1 N-(cyclopropylmethyl)azacycloalkanes, compositions containing them and methods of preparation
06/19/2003WO2003050109A1 Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases
06/19/2003WO2003050099A1 Phenylalkynes
06/19/2003WO2003049736A1 4-substituted piperidines, and methods of use thereof
06/19/2003WO2003049735A1 Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders
06/19/2003WO2003049681A2 Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
06/19/2003US20030114521 Oxamic acids and derivatives as thyroid receptor ligands
06/19/2003US20030114517 Substituted urea neuropeptide Y Y5 receptor antagonists
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114498 A therapeutic agent for cancer-associated neuropathy, comprising a calcium antagonist, a dihydropyridine compounds, nilvadipine
06/19/2003US20030114496 Treatment or prevention of Alzheimer's disease
06/19/2003US20030114490 New phenylalanine derivatives
06/19/2003US20030114489 Asthma therapy; antiallergens; antiinflammatory agents
06/19/2003US20030114488 New processes for producing beta-alanine derivatives
06/19/2003US20030114443 Viricides, Aids therapy
06/19/2003US20030114439 Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
06/19/2003US20030114436 3-substituted piperidines comprising urea functionality, and methods of use thereof
06/19/2003US20030114423 Arylamines as inhibitors of chemokine binding to US28
06/19/2003US20030114365 Neurotrophic pipecolic acid derivative compounds having an affinity for FKBP-type immunophilins; treating neurodegenrative disorders
06/19/2003US20030113373 Delivery of multiple doses of medications
06/19/2003US20030113278 Treatment of excessive radiation (e.g. sunburn) exposure
06/19/2003US20030113261 Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system
06/19/2003US20030111641 Yellow pigment mixture comprising pigment violet 19 and a polyamide
06/19/2003CA2469893A1 Phenylalkynes
06/18/2003EP1319054A1 Liquid crystal mixture
06/18/2003EP1318988A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318811A1 Cyclopentyl modulators of chemokine receptor activity
06/18/2003EP1140829A4 Contrast media for angiography
06/18/2003EP1102747B1 Crystalline forms of osanetant
06/18/2003EP0821588B1 Levobupivacaine and its use as an anaesthetic in pregnant women
06/18/2003EP0749423B1 Piperidines and pyrrolidines
06/18/2003CN1425013A Phenyl substituted 4-hydroxy tetrahydropyridone
06/18/2003CN1425005A Cyclic quaternary ammonium compound
06/18/2003CN1425004A N-substituted metal proteinase inhibitor with heterocyclic side chain
06/18/2003CN1425002A Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders
06/18/2003CN1111561C Compositions for the stabilization of synthetic polymers and its application
06/18/2003CN1111534C Substituted piperidine-epoxide, its preparation and intermediate and use
06/17/2003US6579971 Method of producing 3,4-dehydroprolines and 3,4-dehydropiperidines
06/17/2003US6579889 Substituted isonipecotyl derivatives as inhibitors of cell adhesion
06/17/2003US6579881 Muscle relaxants, antiserotonine agent
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/17/2003US6579328 Preparation from a sterically hindered nitroxy compound and a diazonium salt of an aromatic amine in the presence of a transition metal catalyst
06/17/2003CA2040606C Chiral catalysts for reduction of ketones and process for their preparation
06/12/2003WO2003048142A1 Substituted 6-membered n-heterocyclic compounds and their uses as neurological regulator
06/12/2003WO2003048126A1 Process for the preparation of (2s)-3-[4-({[4-(aminocarbonyl)-1-piperidinyl]carbonyl}oxy) phenyl]2-{((2s)-4-methyl-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino[propanoic acid and intermediates therefore
06/12/2003WO2003048125A1 Aminotetralin derivatives as muscarinic receptor antagonists
06/12/2003WO2003048124A1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
06/12/2003WO2003048118A1 5-ht7 receptor antagonists
06/12/2003WO2003048113A1 Tramadol analogs and uses thereof
06/12/2003WO2003047569A1 Compositions and methods for inhibiting prenyltransferases
06/12/2003WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003WO2003005962A3 Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidate
06/12/2003WO2002047679A3 Nonpeptide agonists and antagonists of vasopressin receptors
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109711 Process for the preparation of 4-haloalkylnicotinonitriles
06/12/2003US20030109710 Viricides, Aids, herpes virus
06/12/2003US20030109706 Serine pretease inhibitors
06/12/2003US20030109704 Long chain hindered amines and compositions stabilized therewith
06/12/2003US20030109700 Antilipemic agents, anticholesterol agents, cardiovascular disorders, antiischemic agents
06/12/2003US20030109564 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109556 Melanocortin receptor ligands
06/12/2003US20030109533 New benzenesulphonamide compounds
06/12/2003US20030109532 Modulators of dopamine neurotransmission
06/12/2003US20030109527 Novel hydroxy diphenylurea sulfonamides, compositions and intermediates thereof. The hydroxy
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/12/2003US20030109517 Azacycloalkanone serine protease inhibitors
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
06/12/2003CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/11/2003EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
06/11/2003EP1317432A1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors
06/11/2003EP1317431A2 Polyarylcarboxamides useful as lipid lowering agents
1 ... 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 ... 380